A new TB vaccine is one step closer after strong trial results

Tuberculosis still kills over a million people a year, and the century-old BCG shot barely protects adults. The M72 vaccine, tested in South Africa, showed it can protect adults and teens from the lung disease — the closest the world has come to a new TB vaccine in decades.